PRR15, which was downregulated in siSHMT2 samples, is a negative regulator for the malignant progression and a clinical prognosis predictor of breast cancer by modulating the PI3K/Akt signaling (Guo et al., 2023). This evidence concerns the gene AKT1 and breast carcinoma.